DK0969821T3 - Pellets, der har en kerne coatet med et antifungalt middel og en polymer - Google Patents

Pellets, der har en kerne coatet med et antifungalt middel og en polymer

Info

Publication number
DK0969821T3
DK0969821T3 DK98919155T DK98919155T DK0969821T3 DK 0969821 T3 DK0969821 T3 DK 0969821T3 DK 98919155 T DK98919155 T DK 98919155T DK 98919155 T DK98919155 T DK 98919155T DK 0969821 T3 DK0969821 T3 DK 0969821T3
Authority
DK
Denmark
Prior art keywords
pellets
polymer
antifungal agent
core coated
coated
Prior art date
Application number
DK98919155T
Other languages
English (en)
Inventor
Roger Petrus Gerebe Vandecruys
Paul Marie Victor Gilis
Jozef Peeters
Conde Valentin Florent Vict De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0969821T3 publication Critical patent/DK0969821T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK98919155T 1997-03-26 1998-03-18 Pellets, der har en kerne coatet med et antifungalt middel og en polymer DK0969821T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200914 1997-03-26
PCT/EP1998/001773 WO1998042318A1 (en) 1997-03-26 1998-03-18 Pellets having a core coated with an antifungal and a polymer

Publications (1)

Publication Number Publication Date
DK0969821T3 true DK0969821T3 (da) 2003-09-15

Family

ID=8228147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98919155T DK0969821T3 (da) 1997-03-26 1998-03-18 Pellets, der har en kerne coatet med et antifungalt middel og en polymer

Country Status (30)

Country Link
EP (1) EP0969821B1 (da)
JP (1) JP3608800B2 (da)
KR (1) KR100520936B1 (da)
CN (1) CN1206984C (da)
AP (1) AP1227A (da)
AT (1) ATE241969T1 (da)
AU (1) AU734248B2 (da)
BG (1) BG64434B1 (da)
BR (1) BR9806174A (da)
CA (1) CA2269501C (da)
CY (1) CY2384B1 (da)
CZ (1) CZ295502B6 (da)
DE (1) DE69815316T2 (da)
DK (1) DK0969821T3 (da)
EE (1) EE03904B1 (da)
ES (1) ES2201485T3 (da)
HU (1) HU224217B1 (da)
ID (1) ID21477A (da)
IL (1) IL129575A (da)
NO (1) NO325102B1 (da)
NZ (1) NZ335364A (da)
OA (1) OA11162A (da)
PL (1) PL190566B1 (da)
PT (1) PT969821E (da)
RU (1) RU2218153C2 (da)
SI (1) SI0969821T1 (da)
SK (1) SK284813B6 (da)
TR (1) TR199900990T2 (da)
UA (1) UA60318C2 (da)
WO (1) WO1998042318A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9906712A (pt) * 1998-07-17 2000-10-10 Janssen Pharmaceutica Nv Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
ES2251985T3 (es) 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
KR100432949B1 (ko) * 2000-06-13 2004-05-31 코오롱제약주식회사 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
ES2275866T3 (es) 2001-02-14 2007-06-16 Tibotec Pharmaceuticals Ltd. 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
AR035819A1 (es) 2001-04-09 2004-07-14 Tibotec Pharm Ltd 2-(amino sustituido)-benzoxazol sulfonamidas, inhibidoras de la proteasa del hiv, composiciones farmaceuticas que comprenden dichos compuestos, metodo in vitro para inhibir la replicacion retroviral y uso de dichos compuestos en la fabricacion de medicamentos
EA009590B1 (ru) 2001-05-11 2008-02-28 Тиботек Фармасьютикалз Лтд. 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
WO2002100407A1 (en) * 2001-06-12 2002-12-19 Smartrix Technologies Inc. Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
JP4578101B2 (ja) 2001-12-21 2010-11-10 テイボテク・フアーマシユーチカルズ・リミテツド 幅広いスペクトルのｈｉｖプロテアーゼ阻害剤である複素環置換フェニル含有スルホンアミド
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
KR101019648B1 (ko) 2002-05-17 2011-03-07 티보텍 파마슈티컬즈 광범위 스펙트럼의 치환된 벤즈이속사졸 설폰아미드ｈｉｖ 프로테아제 저해제
JP4681296B2 (ja) 2002-08-14 2011-05-11 テイボテク・フアーマシユーチカルズ・リミテツド スペクトルの広い置換オキシインドールスルホンアミドｈｉｖプロテアーゼ阻害剤
KR100557680B1 (ko) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
EP1438960B2 (en) * 2003-01-14 2012-12-19 Acino Pharma AG Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
WO2005013939A1 (en) 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
UA84020C2 (ru) 2003-09-11 2008-09-10 Тиботек Фармасьютикелз Лтд. Ингибитор проникновения вируса вил
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
EP2422781A1 (en) 2004-05-07 2012-02-29 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
CN1953982B (zh) 2004-05-17 2011-07-06 泰博特克药品有限公司 4-取代-1,5-二氢-吡啶并[3,2-b]吲哚-2-酮
TW200607503A (en) 2004-05-17 2006-03-01 Tibotec Pharm Ltd 1-heterocyclyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
ES2351702T3 (es) 2004-05-17 2011-02-09 Tibotec Pharmaceuticals 1-fenil-1,5-dihidro-pirido[3,2-b]indol-2-onas 6,7,8,9-sustituidas útiles como agentes farmacéuticos antiinfecciosos.
US7994187B2 (en) 2006-04-03 2011-08-09 Tibotec Pharmaceuticals Ltd. HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones
CA2661172A1 (en) * 2006-09-04 2008-05-29 Panacea Biotec Limited Programmable buoyant delivery technology
KR100809903B1 (ko) * 2006-09-05 2008-03-06 주식회사유한양행 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
US8569364B2 (en) 2007-11-28 2013-10-29 Sequoia Pharmaceuticals, Inc. 5-substituted benzofurans as inhibitors of cytochrome P450 2D6
US8906647B2 (en) 2008-02-21 2014-12-09 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome P450
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
JP5852640B2 (ja) * 2010-05-11 2016-02-03 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ポロゲン組成物、製造方法、および使用
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
CA2895083A1 (en) 2012-12-13 2014-06-19 Allergan, Inc. Device and method for making a variable surface breast implant
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
WO2017127073A1 (en) * 2016-01-20 2017-07-27 Theravida, Inc. Methods and compositions for treating hyperhidrosis
PT3781132T (pt) * 2018-04-16 2024-05-16 Pfizer Formulações de apixabano
CN114767636B (zh) * 2022-04-11 2023-11-07 苏州中化药品工业有限公司 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
DE68915132T2 (de) * 1988-12-22 1994-12-08 American Cyanamid Co., Wayne, N.J. Verfahren zur Behandlung von Periodontitis durch protrahierte Wirkstoffabgabe von Arzneimitteln in der Zahnhöhle, Zusammensetzung davon und Vorrichtung zur Verabreichung.
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound

Also Published As

Publication number Publication date
TR199900990T2 (xx) 1999-10-21
HU224217B1 (hu) 2005-06-28
EE9900453A (et) 2000-04-17
IL129575A (en) 2004-06-20
EP0969821B1 (en) 2003-06-04
EP0969821A1 (en) 2000-01-12
EE03904B1 (et) 2002-12-16
JP2001520663A (ja) 2001-10-30
CZ139899A3 (cs) 1999-10-13
KR100520936B1 (ko) 2005-10-17
ATE241969T1 (de) 2003-06-15
SI0969821T1 (en) 2003-10-31
BG64434B1 (en) 2005-02-28
CN1244796A (zh) 2000-02-16
NZ335364A (en) 2000-08-25
ID21477A (id) 1999-06-17
NO992114D0 (no) 1999-04-30
SK54499A3 (en) 2000-01-18
CA2269501C (en) 2005-11-08
RU2218153C2 (ru) 2003-12-10
IL129575A0 (en) 2000-02-29
PL335542A1 (en) 2000-04-25
AP9901516A0 (en) 1999-06-30
PT969821E (pt) 2003-10-31
BR9806174A (pt) 1999-10-19
CA2269501A1 (en) 1998-10-01
KR20000052971A (ko) 2000-08-25
CN1206984C (zh) 2005-06-22
BG103356A (en) 2000-03-31
JP3608800B2 (ja) 2005-01-12
NO992114L (no) 1999-08-26
OA11162A (en) 2003-04-16
HUP0002056A2 (hu) 2000-12-28
CY2384B1 (en) 2004-06-04
DE69815316T2 (de) 2004-04-29
DE69815316D1 (de) 2003-07-10
AP1227A (en) 2003-11-24
NO325102B1 (no) 2008-02-04
PL190566B1 (pl) 2005-12-30
CZ295502B6 (cs) 2005-08-17
HUP0002056A3 (en) 2001-01-29
UA60318C2 (uk) 2003-10-15
SK284813B6 (sk) 2005-12-01
WO1998042318A1 (en) 1998-10-01
AU7210798A (en) 1998-10-20
HK1022840A1 (en) 2000-08-25
AU734248B2 (en) 2001-06-07
ES2201485T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
DK0969821T3 (da) Pellets, der har en kerne coatet med et antifungalt middel og en polymer
DK1104291T3 (da) Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
FI960181A7 (fi) Substituoituja 2-fenyylipyridiinejä, joilla on rikkaruohomyrkkyvaikutus
NL1005115A1 (nl) Kogeltjesmatrixsondesamenstel.
NO20005630D0 (no) Mikro-laser-kuler og strukturer, og tilhörende fremgangsmåter
NO980450D0 (no) Induserbar herbicidresistens
DK1009597T3 (da) Barberingssystem, der har skaft og udskiftelig kassette
DE69823810D1 (de) Anrufumleitungssystem mit anpassungsfähigem benutzerverhaltensmodell
NO20006058D0 (no) Et töyelig, kveilbart element
FI956337A7 (fi) Absorboiva ydin, jolla on parantuneet nesteenkäsittelyominaisuudet
FI956322L (fi) Elektroninen laite, jossa on saranarakenne
FI950975L (fi) Antifungaalisella aineella ja polymeerilla päällystetyn ytimen käsittäviä helmiä
DE69938207D1 (de) Anzeigegerät mit aktiver Matrix
DE69916184D1 (de) Rundballenpresse mit Garnwickelkontrole
DE69520717D1 (de) Kassette, Aufbewahrungsbehälter, und Etikett für dergleiche Kassette und Aufbewahrungsbehälter
ITAL940001V0 (it) Amo da pesca, particolarmente per spinning o simili, a zavorra varia- bile ed intercambiabile.
PT1074551E (pt) Fenilpirazois com actividade herbicida
NO20005426D0 (no) Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer
DK199900207A (da) Tilslutningsliste og på en tilslutningsliste påsættelig overspændingsbeskyttelsesmagasin
NO992690D0 (no) Nye calpainer, fremstilling og anvendelse derav
FI964447A7 (fi) Kytkin, jolla on kontrolloidut nousu- ja laskuominaisuudet
NO995027L (no) Datamelding gjennom telefonnett uten oppkoblingstid
ID30440A (id) Baut friksi dengan inti fleksible
ITMO970122A0 (it) Attrezzo particolarmente per allenamento ginnico sportivo e relativo u so.
FI962923L (fi) Uusi glykoproteiini-isomuotokoostumus, jolla on follikkelia stimuloiva aktiivisuus